| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | H02AA01 |
| UNII: | 4964P6T9RB |
| InChI Key | PQSUYGKTWSAVDQ-ZVIOFETBSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H28O5 |
| Molecular Weight | 360.45 |
| AlogP | 1.85 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 91.67 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 26.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 7-14 | |
|
Secreted protein
|
- | - | 4786 | 525 | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 2
|
0-4 | 0-9 | 1 | - | - |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Inflammation | Phase 1 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 52-39-1 |
| ChEBI | 27584 |
| ChEMBL | CHEMBL273453 |
| DrugBank | DB04630 |
| DrugCentral | 111 |
| EPA CompTox | DTXSID7022419 |
| FDA SRS | 4964P6T9RB |
| Guide to Pharmacology | 3452 |
| KEGG | C01780 |
| PDB | AS4 |
| PubChem | 5839 |
| SureChEMBL | SCHEMBL1675 |
| ZINC | ZINC000003833824 |